JY
SRTA

Jeff Yass’s Strata Critical Medical Inc SRTA Stock Holding History

Jeff Yass’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$870K Buy
165,100
+129,700
+366% +$682K ﹤0.01% 8555
2026
Q1 		$148K Buy
35,400
+11,800
+50% +$56.8K ﹤0.01% 12017
2025
Q4 		$114K Sell
23,600
-380,800
-94% -$1.84M ﹤0.01% 11381
2025
Q3 		$2.05M Buy
404,400
+9,400
+2% +$41.5K ﹤0.01% 5752
2025
Q2 		$1.59M Buy
395,000
+367,700
+1,347% +$1.2M ﹤0.01% 6288
2025
Q1 		$74.5K Buy
27,300
+11,700
+75% +$42K ﹤0.01% 11712
2024
Q4 		$66.3K Buy
+15,600
New +$59.4K ﹤0.01% 11562
2024
Q2 		– Sell
-33,700
Closed -$96K – 12059
2024
Q1 		$96K Buy
+33,700
New +$104K ﹤0.01% 11242
2022
Q4 		– Sell
-14,900
Closed -$60K – 12434
2022
Q3 		$60K Sell
14,900
-5,100
-26% -$26.2K ﹤0.01% 12088
2022
Q2 		$89K Sell
20,000
-57,100
-74% -$412K ﹤0.01% 11571
2022
Q1 		$655K Sell
77,100
-116,300
-60% -$817K ﹤0.01% 8248
2021
Q4 		$1.71M Buy
193,400
+10,800
+6% +$103K ﹤0.01% 5889
2021
Q3 		$1.9M Buy
182,600
+7,300
+4% +$63.8K ﹤0.01% 5946
2021
Q2 		$1.84M Sell
175,300
-72,300
-29% -$714K ﹤0.01% 6106
2021
Q1 		$2.55M Buy
+247,600
New +$3.44M ﹤0.01% 5336

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's SRTA Position: Q2 2026 in Review

Jeff Yass reduced its Strata Critical Medical Inc (SRTA) stake by 57% in Q2 2026, selling an estimated $79.7K and leaving 11,510 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12757.

Jeff Yass first reported a position in SRTA in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.74M in Q1 2021. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Jeff Yass held 11,510 shares of Strata Critical Medical Inc worth $60.7K as of Q2 2026.
  • Jeff Yass sold 15,151 Strata Critical Medical Inc shares in Q2 2026, an estimated $79.7K.
  • Strata Critical Medical Inc made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12757 holding.
  • Jeff Yass first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 22 quarters since.
  • Jeff Yass's Strata Critical Medical Inc position peaked at $3.74M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.